The NeuroCognitive Institute is a clinical research site located in Mount Arlington, New Jersey, United States 07856.
Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.
The NeuroCognitive Institute has participated in 15 clinical trials.
Therapeutic areas: Attention-deficit/Hyperactivity Disorder, Neuropsychiatric Symptoms Related to Neurodegenerative Disease, Mild Cognitive Impairment.
Sponsors: Shire, ACADIA Pharmaceuticals Inc., AgeneBio.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in New Jersey · View every site in Mount Arlington
Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The NeuroCognitive Institute has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The NeuroCognitive Institute has 15 clinical trials on record. Their work covers Attention-deficit/Hyperactivity Disorder, Neuropsychiatric Symptoms Related to Neurodegenerative Disease, Mild Cognitive Impairment.
The NeuroCognitive Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.